An improved nicotinic pharmacophore and a stereoselective CoMFA-model for nicotinic agonists acting at the central nicotinic acetylcholine receptors labelled by [3H]-N-methylcarbamylcholine

No abstract is available for this paper.

• Publication year

  2001

• Venue

  J. Comput. Aided Mol. Des.

• Publication date

  2001-03-01

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1023/A:1008140021426PMID 11289078
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bioisosteric replacement strategy for the synthesis of 1-azacyclic compounds with high affinity for the central nicotinic cholinergic receptors.

  2000cited by this paper
• Improving the nicotinic pharmacophore with a series of (Isoxazole)methylene-1-azacyclic compounds: synthesis, structure-activity relationship, and molecular modeling.

  1999cited by this paper
• 分子 similarity 解析によるネオニコチノイド系殺虫剤の三次元構造活性相関

  1999cited by this paper
• Synthesis and binding of 6,7,8,9-tetrahydro-5H-pyrido[3,4-d]azepine and related ring-opened analogs at central nicotinic receptors

  1999cited by this paper
• 2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling.

  1998cited by this paper
• A Critical Review of Recent CoMFA Applications

  1998cited by this paper
• Prediction of the Binding Mode of Imidacloprid and Related Compounds to House-Fly Head Acetylcholine Receptors Using Three-Dimensional QSAR Analysis

  1998cited by this paper
• Neuronal nicotinic acetylcholine receptors as targets for drug discovery.

  1997cited by this paper
• Synthesis of UB-165: A novel nicotinic ligand and anatoxin-a/epibatidine hybrid

  1997cited by this paper
• Synthesis and nicotinic activity of epiboxidine: an isoxazole analogue of epibatidine.

  1997cited by this paper
• Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94

  1996cited by this paper
• Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.

  1996cited by this paper
• Merck molecular force field. IV. conformational energies and geometries for MMFF94

  1996cited by this paper
• Merck molecular force field. III. Molecular geometries and vibrational frequencies for MMFF94

  1996cited by this paper
• Pyrrolidine-modified and 6-substituted analogs of nicotine: A structure—affinity investigation

  1996cited by this paper
• Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions

  1996cited by this paper
• Structure – activity relationships of nicotinic acetylcholine receptor agonists as potential treatments for dementia

  1995cited by this paper
• Epibatidine, a potent analgetic and nicotinic agonist.

  1994cited by this paper
• Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics

  1990cited by this paper
• Semianalytical treatment of solvation for molecular mechanics and dynamics

  1990cited by this paper
• Stereoselectivity of nicotinic receptors.

  1989cited by this paper
• Chapter 8 Stereoselectivity of nicotinic receptors

  1989cited by this paper
• A rapid approximation to the solvent accessible surface areas of atoms

  1988cited by this paper
• Anatoxin-a a potent ligand for nicotinic cholinergic receptors in rat brain.

  1987cited by this paper
• The ensemble approach to distance geometry: application to the nicotinic pharmacophore.

  1986cited by this paper
• Structure and Activity of Acetylcholine

  1970cited by this paper

• Differential Activation and Desensitization States Promoted by Noncanonical α7 Nicotinic Acetylcholine Receptor Agonists

  2022cites this paper
• Differential Activation and Desensitization States Promoted by Non-canonical α7 nAChR Agonists

  2022cites this paper
• The α7 nAChR selective agonists as drug candidates for Alzheimer's disease.

  2015cites this paper
• Merging old and new perspectives on nicotinic acetylcholine receptors.

  2014cites this paper
• Synthesis and differential functionalisation of pyrrolidine and piperidine based spirodiamine scaffolds

  2013cites this paper
• Structure-Function Studies of Nicotinic Acetylcholine Receptors Using Unnatural Amino Acids and Synthetic Agonist Analogs

  2012cites this paper
• Computational analysis of the binding ability of heterocyclic and conformationally constrained epibatidine analogs in the neuronal nicotinic acetylcholine receptor

  2010cites this paper
• Preparation and characterization of N-(3-pyridinyl) spirocyclic diamines as ligands for nicotinic acetylcholine receptors.

  2009cites this paper
• 3D-QSAR and QSSR studies of 3,8-diazabicyclo[4.2.0]octane derivatives as neuronal nicotinic acetylcholine receptors by comparative molecular field analysis (CoMFA).

  2009cites this paper
• Multiple Pharmacophores for the Selective Activation of Nicotinic α7-Type Acetylcholine Receptors

  2008cites this paper
• QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.

  2007cites this paper
• Central Nicotinic Receptors: Structure, Function, Ligands, and Therapeutic Potential

  2007cites this paper
• Synthesis and nicotinic acetylcholine receptor binding properties of bridged and fused ring analogues of epibatidine.

  2007cites this paper
• QSAR study of a large set of 3-pyridyl ethers as ligands of the α4β2 nicotinic acetylcholine receptor

  2007cites this paper
• Nicotinic Acetylcholine Receptors as a Continuous Source for Rational Insecticides

  2007cites this paper
• Hydrogen-bond interactions of nicotine and acetylcholine salts: a combined crystallographic, spectroscopic, thermodynamic and theoretical study.

  2007cites this paper
• Computational evidence for the ligand selectivity to the α4β2 and α3β4 nicotinic acetylcholine receptors

  2006cites this paper
• Computational evidence for the ligand selectivity to the alpha4beta2 and alpha3beta4 nicotinic acetylcholine receptors.

  2006cites this paper
• SYNTHESIS AND EVALUATION OF PYRIDINIUM DERIVATIVES AS CENTRAL NERVOUS SYSTEM NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

  2006cites this paper
• The Chemistry and Pharmacology of Anatoxin-a and Related Homotropanes with respect to Nicotinic Acetylcholine Receptors

  2006cites this paper
• Synthesis of Epibatidine‐Related Δ2‐Isoxazoline Derivatives and Evaluation of Their Binding Affinity at Neuronal Nicotinic Acetylcholine Receptors

  2006cites this paper
• Synthesis and binding studies of epibatidine analogues as ligands for the nicotinic acetylcholine receptors.

  2006cites this paper
• 6-(2-Phenylethyl)nicotine: a novel nicotinic cholinergic receptor ligand.

  2005cites this paper
• 3-(2-Aminoethyl)pyridine analogs as alpha4beta2 nicotinic cholinergic receptor ligands.

  2005cites this paper
• Molecular modeling of mono- and bis-quaternary ammonium salts as ligands at the α4β2 nicotinic acetylcholine receptor subtype using nonlinear techniques

  2005cites this paper
• CoMFA, CoMSIA, and Molecular Hologram QSAR Studies of Novel Neuronal nAChRs Ligands-Open Ring Analogues of 3-Pyridyl Ether

  2005cites this paper
• Rigid analogs of DMPP as probes for the nicotinic receptors.

  2005cites this paper
• 3-(2-Aminoethyl)pyridine analogs as α4β2 nicotinic cholinergic receptor ligands

  2005cites this paper
• Nicotinic acetylcholine receptor ligands as potential therapeutics

  2005cites this paper
• Novel Nicotinic Acetylcholine Receptor Ligands based on Cytisine, Ferruginine, Anatoxin-a and Choline: In vitro Evaluation and Structure-Activity Relationships

  2004cites this paper
• 3-(4-Aminobutyn-1-yl)pyridines: binding at alpha 4 beta 2 nicotinic cholinergic receptors.

  2004cites this paper
• Medicinal Chemistry of α4β2 Nicotinic Cholinergic Receptor Ligands

  2004cites this paper
• 3-(4-Aminobutyn-1-yl)pyridines: binding at α4β2 nicotinic cholinergic receptors

  2004cites this paper
• α4β2 nACh Receptor pharmacophore models

  2004cites this paper
• Identifying the binding mode of a molecular scaffold

  2004cites this paper
• alpha4beta2 nACh receptor pharmacophore models.

  2004cites this paper
• Musings on alpha4beta2 nicotinic acetylcholine (nACh) receptor pharmacophore models.

  2004cites this paper
• 2. Medicinal chemistry of alpha4beta2 nicotinic cholinergic receptor ligands.

  2004cites this paper
• Neuronal nicotinic acetylcholine receptor agonists: pharmacophores, evolutionary QSAR and 3D-QSAR models.

  2003cites this paper
• Halogenated cytisine derivatives as agonists at human neuronal nicotinic acetylcholine receptor subtypes.

  2003cites this paper
• Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.

  2003cites this paper
• Binding of nicotine and homoazanicotine analogues at neuronal nicotinic acetylcholinergic (nACh) receptors.

  2003cites this paper
• Synthesis and nicotinic binding of novel phenyl derivatives of UB-165. Identifying factors associated with alpha7 selectivity.

  2003cites this paper
• Cholinergic nicotinic receptors: Competitive ligands, allosteric modulators, and their potential applications

  2003cites this paper
• 3D QSAR analyses-guided rational design of novel ligands for the (alpha4)2(beta2)3 nicotinic acetylcholine receptor.

  2003cites this paper
• 3D QSAR Analyses-Guided Rational Design of Novel Ligands for the (α4)2(β2)3 Nicotinic Acetylcholine Receptor

  2003cites this paper
• Epibatidine: Impact on Nicotinic Receptor Research

  2003influential citation
• Conformationally constrained nicotines: polycyclic, bridged, and spiro-annulated analogues as novel ligands for the nicotinic acetylcholine receptor.

  2002cites this paper
• A review of molecular modeling approaches to pharmacophore models and structure-activity relationships of ion channel modulators in CNS.

  2002cites this paper
• Synthesis and evaluation of a novel series of 2-chloro-5-((1-methyl-2-(S)-pyrrolidinyl)methoxy)-3-(2-(4-pyridinyl)vinyl)pyridine analogues as potential positron emission tomography imaging agents for nicotinic acetylcholine receptors.

  2002cites this paper
• Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165.

  2002cites this paper
• Neuronal nicotinic receptor agonists: a multi-approach development of the pharmacophore

  2001cites this paper
• Structure-affinity relationships of a unique nicotinic ligand: N(1)-dimethyl-N(4)-phenylpiperazinium iodide (DMPP).

  2001cites this paper
• D QSAR Analyses-Guided Rational Design of Novel Ligands for the ( r 4 ) 2 ( â 2 ) 3 Nicotinic Acetylcholine Receptor

  year unknowncites this paper
• CHAPTER 
 4 : 
 Stereochemical 
 Preferences 
 of 
 the 
 Nicotinic 
 Receptor : 
 
 Pharmacophore 
 Binding 
 Interactions 
 of 
 Epibatidine 
 Enantiomers

  year unknowncites this paper